Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,851 public trials 1,786 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

NCT07368998

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Astera Cancer Care East Brunswick East Brunswick, New Jersey, United States
  • Instituto de Oncologia de Rosario Rosario, Santa Fe Province, Argentina
  • Centro Oncologico Korben Ciudad Autonoma Buenos Aires, Argentina
View all 34 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

NCT05315700

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Huntington Beach, California, United States
  • City of Hope Irvine, California, United States
  • City of Hope Long Beach, California, United States
View all 42 locations
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT06312176

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Ironwood Cancer & Research Centers ( Site 0066) Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center-Oncology ( Site 0004) Gilbert, Arizona, United States
  • Providence Medical Foundation-Oncology ( Site 0020) Fullerton, California, United States
  • Moores Cancer Center ( Site 0059) La Jolla, California, United States
View all 259 locations
View Trial Details
Recruiting

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

NCT06982521

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 231 locations
View Trial Details
Recruiting

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

NCT05590949

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details

Related conditions